tiprankstipranks
Trending News
More News >
JBT Marel (JBTM)
NYSE:JBTM

JBT Marel (JBTM) AI Stock Analysis

Compare
245 Followers

Top Page

JB

JBT Marel

(NYSE:JBTM)

Rating:70Outperform
Price Target:
$129.00
▲(2.00%Upside)
JBTM's overall stock score reflects a stable financial foundation and strong cash generation capabilities, bolstered by positive earnings call insights. However, the negative net income and valuation concerns, coupled with tariff uncertainties, weigh down the score.
Positive Factors
Commercial Synergies
JBT Marel is already seeing the early benefits of commercial synergies with early wins driven by bundling of its end-to-end poultry offering.
Financial Performance
JBT Marel reported strong first-quarter results as both revenue and orders were above expectations.
Order Growth
Order momentum continued in first quarter 2025 with record bookings at Marel, led by poultry, implying significant year-over-year growth.
Negative Factors
Acquisition Dilution
Year one dilution from the acquisition of Marel is more adverse than originally feared, at an estimated $0.65 to $1.25.
Guidance Suspension
The decision to suspend full year 2025 guidance appears to stem from an abundance of caution, with JBT Marel citing prolonged periods of macro uncertainty.
Tariff Uncertainty
The looming potential of 50% EU tariffs adds another layer of complexity during an already complex integration process.

JBT Marel (JBTM) vs. SPDR S&P 500 ETF (SPY)

JBT Marel Business Overview & Revenue Model

Company DescriptionJBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market. In addition, it offers automated guided vehicle systems for material movement in the manufacturing, warehouse, and medical facilities. It serves baby food, bakery and confectionery, citrus processing, fruits and nuts, juices, non-food, pet food, pharmaceutical, plant- based beverages and protein, poultry, meat, and seafood, ready meals, oils, soups, sauces, seasoning and dressings, automotive, building material, tissue, paper, and packaging, hospitals, pharma and life sciences, fast moving consumer goods, manufacturing, warehousing, and other industries. The company markets and sells its products and solutions through direct sales force, independent distributors, sales representatives, and technical service teams. The company was formerly known as John Bean Technologies Corporation and changed its name to JBT Marel Corporation in January 2025. JBT Marel Corporation was incorporated in 1994 and is headquartered in Chicago, Illinois.
How the Company Makes MoneyJBT Marel makes money through the sale of its advanced food processing equipment and systems, which are designed to improve operational efficiency and product quality for its customers. The company generates revenue from both the initial sale of its machinery and ongoing service contracts, including maintenance and support services. JBT Marel also engages in aftermarket sales, providing spare parts and upgrades to its installed equipment base. Strategic partnerships with key players in the food processing industry and continual investment in research and development further bolster its revenue streams by enabling the company to offer cutting-edge solutions and capture new market opportunities.

JBT Marel Earnings Call Summary

Earnings Call Date:May 05, 2025
(Q1-2025)
|
% Change Since: 18.13%|
Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment Neutral
JBT Marel's earnings call highlighted strong performance in revenue and order growth, successful integration efforts, and a solid liquidity position. However, the suspension of full-year guidance due to tariff uncertainties and challenges in specific market segments like whitefish present notable risks. Overall, while positive achievements were significant, the uncertainties and potential financial impacts of tariffs weigh on the outlook.
Q1-2025 Updates
Positive Updates
Better-than-Expected Revenue and Margin Performance
JBT Marel's first quarter revenue exceeded the midpoint of guidance by $19 million, outperforming expectations due to strong equipment shipments and recurring revenue. Adjusted EBITDA margin was 13.1%, surpassing guidance by 60 basis points.
Strong Order Growth
Orders increased 12% year over year, with significant demand from the Poultry industry and robust orders in meat, beverage, pharma, and pet food sectors. Combined orders reached $916 million, reflecting healthy growth.
Progress on Integration and Synergy Realization
Significant progress in integrating JBT and Marel, with cost synergies on track to achieve in-year savings of $35 million to $40 million in 2025 and annual run-rate savings of $80 million to $90 million.
Strong Liquidity Position
The company has a liquidity of approximately $1.3 billion, providing significant financial flexibility, with a reduction in leverage to 3.8 times, improving from just below 4 times at transaction close.
Negative Updates
Impact of Tariffs and Economic Uncertainty
Temporary suspension of full-year financial guidance due to uncertainty from US tariffs and potential reciprocal tariffs. Estimated cost impact of $50 million to $60 million annually due to tariffs.
Challenges in Whitefish Market
Continued challenges in the whitefish market, with a 25% quota reduction in the Barents Sea for 2025, impacting demand and market conditions.
Potential Backlog Repricing
Discussions with customers about potential repricing of backlog orders due to tariff impacts, which may affect revenue and margin stability.
Company Guidance
During JBT Marel's Q1 2025 earnings call, the company reported strong performance, exceeding revenue and adjusted EBITDA guidance, with a 13.1% adjusted EBITDA margin surpassing expectations by 60 basis points. Orders increased by 12% year-over-year, driven by robust demand in the poultry, meat, beverage, pharma, and pet food sectors across various global regions. Despite macroeconomic uncertainties and US tariff impacts, JBT Marel suspended its full-year guidance, offering only Q2 projections, anticipating $885 million to $915 million in revenue and an adjusted EBITDA margin between 14.5% and 15.25%. The company estimated potential tariff costs of $50 million to $60 million annually but plans to mitigate these by over half through supplier negotiations, pricing adjustments, and manufacturing shifts. The integration of JBT and Marel is on track, with targeted annual run-rate synergy savings of $150 million expected by the end of 2027.

JBT Marel Financial Statement Overview

Summary
JBT Marel exhibits a stable financial foundation with strong cash generation capabilities and improved balance sheet strength. However, the recent net loss and declining profit margins highlight the need for operational efficiencies and cost control. The company should focus on reversing the net income trend to sustain long-term growth.
Income Statement
65
Positive
The income statement shows a mixed performance. The revenue growth rate for TTM is strong compared to the previous annual period, but the company posted a negative net income. Gross profit margin remains healthy, yet the net profit margin is concerning due to the significant net loss in the TTM. EBIT and EBITDA margins have decreased, reflecting challenges in maintaining operational efficiency.
Balance Sheet
72
Positive
The balance sheet is relatively robust with a high equity ratio, indicating strong capitalization. Debt levels have been reduced significantly, improving the debt-to-equity ratio favorably. However, the return on equity has been negatively impacted by the net loss, which may be a potential risk if profitability issues persist.
Cash Flow
78
Positive
Cash flow metrics are solid, with a strong operating cash flow to net income ratio indicating effective cash generation from operations. Free cash flow has grown, showing good liquidity management. However, the substantial increase in financing cash flow suggests reliance on external funding, which could indicate potential liquidity concerns in the future if not managed well.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.18B1.72B1.66B1.59B1.40B1.73B
Gross Profit778.70M626.50M585.70M529.40M482.10M533.70M
EBITDA114.90M204.20M268.70M212.50M202.80M231.20M
Net Income-110.40M85.40M582.60M137.40M119.10M108.80M
Balance Sheet
Total Assets8.00B3.41B2.71B2.64B2.14B1.81B
Cash, Cash Equivalents and Short-Term Investments101.00M1.23B483.30M71.70M78.80M47.50M
Total Debt21.40M1.25B646.40M977.90M674.40M524.90M
Total Liabilities3.89B1.87B1.22B1.74B1.39B1.17B
Stockholders Equity4.11B1.54B1.49B905.40M750.20M637.10M
Cash Flow
Free Cash Flow209.20M194.70M19.10M50.60M123.20M217.70M
Operating Cash Flow256.60M232.60M74.20M135.20M174.90M252.00M
Investing Cash Flow-1.80B-41.30M729.30M-413.20M-270.50M-37.30M
Financing Cash Flow1.19B561.80M-354.10M270.60M80.80M-207.40M

JBT Marel Technical Analysis

Technical Analysis Sentiment
Positive
Last Price126.47
Price Trends
50DMA
114.89
Positive
100DMA
117.21
Positive
200DMA
116.21
Positive
Market Momentum
MACD
1.85
Negative
RSI
63.58
Neutral
STOCH
77.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBTM, the sentiment is Positive. The current price of 126.47 is above the 20-day moving average (MA) of 120.81, above the 50-day MA of 114.89, and above the 200-day MA of 116.21, indicating a bullish trend. The MACD of 1.85 indicates Negative momentum. The RSI at 63.58 is Neutral, neither overbought nor oversold. The STOCH value of 77.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JBTM.

JBT Marel Risk Analysis

JBT Marel disclosed 58 risk factors in its most recent earnings report. JBT Marel reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

JBT Marel Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
WTWTS
79
Outperform
$8.52B29.2317.61%0.82%3.89%8.17%
78
Outperform
$8.08B40.0015.24%10.78%30.05%
MWMWA
74
Outperform
$3.86B26.9317.68%1.09%10.96%43.44%
FLFLS
74
Outperform
$7.06B25.3214.00%1.55%4.23%20.40%
70
Outperform
$6.55B40.40-3.97%0.16%30.24%-107.38%
SXSXI
69
Neutral
$2.01B32.849.29%0.77%2.67%-18.41%
65
Neutral
$10.77B15.805.51%1.90%3.03%-26.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JBTM
JBT Marel
126.47
35.29
38.70%
FLS
Flowserve
55.29
9.23
20.04%
MWA
Mueller Water Products
24.79
6.59
36.21%
SPXC
SPX
173.03
29.19
20.29%
SXI
Standex International
168.60
12.07
7.71%
WTS
Watts Water Technologies
255.29
78.32
44.26%

JBT Marel Corporate Events

Executive/Board ChangesShareholder Meetings
JBT Marel Stockholders Approve Key Proposals at Annual Meeting
Neutral
May 20, 2025

On May 15, 2025, JBT Marel Corporation held its Annual Meeting of Stockholders where three key proposals were voted on. The stockholders re-elected three directors, approved executive compensation on an advisory basis, and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the 2025 fiscal year.

The most recent analyst rating on (JBTM) stock is a Sell with a $85.00 price target. To see the full list of analyst forecasts on JBT Marel stock, see the JBTM Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 04, 2025